The effect of pleiotrophin signaling on adipogenesis

Dayong Gu1, Bing Yu, Chen Zhao

  • 1Life Science Division, Graduate School at Shenzhen, Tsinghua University, Room 407, Building L, Tsinghua Campus, University Town, Shenzhen, Guangdong 518055, PR China.

FEBS Letters
|January 24, 2007
PubMed

Insights

Pleiotrophin (PTN) negatively regulates fat cell formation (adipogenesis). PTN signaling interacts with Wnt pathways via GSK-3beta and beta-catenin to control preadipocyte differentiation.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Biochemistry

Background:

  • Pleiotrophin (PTN) is a growth factor involved in cell growth and differentiation.
  • Adipogenesis, the process of fat cell formation, is crucial for energy homeostasis and is tightly regulated.
  • Understanding the molecular mechanisms controlling adipogenesis is vital for metabolic research.

Purpose of the Study:

  • To investigate the role of Pleiotrophin (PTN) in adipogenesis.
  • To elucidate the signaling pathways and key molecules involved in PTN-mediated regulation of preadipocyte differentiation.

Main Methods:

  • Small interfering RNA (siRNA) was used to knock down PTN expression in preadipocytes.
  • Expression levels of key signaling proteins, including phospho-GSK-3beta and beta-catenin, were analyzed.
  • Signaling pathway crosstalk between PTN and Wnt pathways was investigated.

Main Results:

  • Knocking down PTN expression led to increased phospho-GSK-3beta and nuclear beta-catenin accumulation.
  • These molecular changes are indicative of downstream signaling activation.
  • PTN negatively regulates adipogenesis through a PTN/PI3K/AKT/GSK-3beta/beta-catenin pathway.

Conclusions:

  • PTN plays a negative role in adipogenesis.
  • The PTN/PI3K/AKT/GSK-3beta/beta-catenin pathway is identified as a key regulator of preadipocyte differentiation.
  • This pathway crosstalks with the Wnt signaling pathway to modulate adipogenesis.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...